Insulin-like Growth Factor 1 (IGF-1) is a completely natural hormone that your body produces. When you are first born, you already have a high amount of IGF-1 coursing through you, which explains why you grow so much and so quickly when you're a child.   As you get older, your IGF-1 levels diminish, slowing your growth. These smaller levels could account for general fatigue, weakened muscle mass, decreased bone density, and more.   So how do you fix these problems?   Replenishing your IGF-1 levels with Nutronics products can certainly help to get the job done and if you'd like...

The US National Library of Medicine recently released a study that shows IGF-1 may have an effect on physical exercise for women with fibromyalgia. It can help people, specifically women, with fibromyalgia, improve muscle metabolism.Research from the study shows that sudden burst of physical activity or exercise after introducing IGF-1 helps improve muscle metabolism. Muscle metabolism is the use of energy that the muscle produces. This helps moderate the muscles during the high intensity workouts.  What is Fibromyalgia? Fibromyalgia is an arthritis-based disorder characterized by musculoskeletal pain from nerves in different areas of the body. Symptoms include fatigue, difficulty with...

A new study featured by the U.S. National Academy of Sciences, reveals that IGF-1 could help promote bone growth. In the study, IGF-1 was induced via the introduction of gut microbiota, also known as gut flora. Gut microbiota are located in the intestines and perform functions including: Production of necessary vitamins, including vitamins B and K Digestions of foods that have not yet been digested by the stomach Boosts the immune system Maintains proper digestion Fights off problem microorganisms The study introduced gut microbiota to a group of healthy adult mice. Once the gut microbiota was introduced to the mice,...

According to a new study published in The Huffington Post, IGF-1 could help work towards reversing the symptoms of Rett's Syndrome. The article, published October 19, 2016, talks about a study ran from the University of California, San Diego. The study, conducted by Dr. Alysson Muotri, analyzed groups of cells from both "average" patients and those who had abnormal MECP2 cells, which indicates Rett's Syndrome. They grabbed skin cells from both groups and transformed them into stem cells, then administered IGF-1 onto the cells with Rett's Syndrome. Once the IGF-1 was administered, the Rett's Syndrome was not "cured." Rather, IGF-1...